Total item
Cart Subtotal
$0.00 Details
Empagliflozin is a potent, selective sodium glucose co-transporter-2 inhibitor that is in development for the treatment of type 2 diabetes.
Targets
| SGLT2 | SGLT5 | SGLT6 | SGLT1 | SGLT4 |
| 3.1 nM | 1.1 μM | 2 μM | 8.3 μM | 11 μM |
| In vitro (25°C) | DMSO | 90 mg/mL (199.59 mM) | |
| Water | <1 mg/mL (<1 mM) | ||
| Ethanol | <1 mg/mL (<1 mM) | ||
| In vivo | 15% Captisol | 15 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 22.18 mL | 110.89 mL | 221.77 mL |
| 0.5 mM | 4.44 mL | 22.18 mL | 44.35 mL |
| 1 mM | 2.22 mL | 11.09 mL | 22.18 mL |
| 5 mM | 0.44 mL | 2.22 mL | 4.44 mL |
*The above data is based on the productmolecular weight 450.91. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Technical Details
| Catalog Num | A12440 |
|---|---|
| Actions | N/A |
| M. Wt | 450.91 |
| Formula | C23H27ClO7 |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 864070-44-0 |
| Synonyms | N/A |
| SMILES | C1COC[[email protected]]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[[email protected]]4[[email protected]@H]([[email protected]]([[email protected]@H]([[email protected]](O4)CO)O)O)O)Cl |
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy Empagliflozin | Empagliflozin Supplier | purchase Empagliflozin | Empagliflozin cost | Empagliflozin manufacturer | order Empagliflozin | Empagliflozin distributor | buy 864070-44-0| 864070-44-0 Supplier | purchase 864070-44-0 | 864070-44-0 cost | 864070-44-0 manufacturer | order 864070-44-0 | 864070-44-0 distributor
Adooq Quality Guarantee
We promise all products perform as described.